Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455].

Details

Request a copyRequest a copy
Serval ID
serval:BIB_74C3D3CD6DB5
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455].
Journal
ESMO open
Author(s)
König D., Schär S., Vuong D., Guckenberger M., Furrer K., Opitz I., Weder W., Rothschild S.I., Ochsenbein A., Zippelius A., Addeo A., Mark M., Eboulet E.I., Hayoz S., Thierstein S., Betticher D.C., Ris H.B., Stupp R., Curioni-Fontecedro A., Peters S., Pless M., Früh M.
ISSN
2059-7029 (Electronic)
ISSN-L
2059-7029
Publication state
Published
Issued date
06/2022
Peer-reviewed
Oui
Volume
7
Number
3
Pages
100494
Language
english
Notes
Publication types: Published Erratum
Publication Status: ppublish
OAI-PMH
oai:serval.unil.ch:BIB_74C3D3CD6DB5
DOI
10.1016/j.esmoop.2022.100494
Pubmed
35468561
Web of science
001044008800023
Open Access
Yes
Create date
04/04/2023 16:57
Last modification date
28/11/2023 8:12
Usage data